Elissar Moujaes

Dr. Elissar Moujaes


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2021 in Future Oncology
Verified
Journal Article
Open access
EMElissar Moujaes
Elissar Moujaes
NZNaji Bou Zeid
Naji Bou Zeid
RSRamy Samaha
Ramy Samaha
JSJoud Sawan
Joud Sawan
HKHampig Kourie
Hampig Kourie
JKJoseph Kattan
Joseph Kattan
Aims: This paper reports the results of a survey assessing the acceptance of the coronavirus disease 2019 (COVID-19) vaccine among patients with cancer. Patients and methods: In total, 111 adult pa... Lay abstract Major cancer societies consider vaccinating patients with cancer against coronavirus disease 2019 (COVID-19) a priority. The investigators conducted a survey assessing perceptions of t...

1 November 2021 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
MBMarc Boutros
Marc Boutros
EMElissar Moujaes
Elissar Moujaes
HKHampig Raphael Kourie
Hampig Raphael Kourie

1 January 2021 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
AMAhmad Mroue
Ahmad Mroue
EMElissar Moujaes
Elissar Moujaes
HKHampig Raphael Kourie
Hampig Raphael Kourie
HAHiba Azar
Hiba Azar
SFSerge Finianos
Serge Finianos
DCDania Chelala
Dania Chelala

19 August 2021 in Pharmacogenomics
Verified
Journal Article
Closed access
SRSouraya Rammal
Souraya Rammal
HKHampig Raphael Kourie
Hampig Raphael Kourie
NJNadine Jalkh
Nadine Jalkh
CMCybel Mehawej
Cybel Mehawej
ECEliane Chouery
Eliane Chouery
GDGeorges Dabar
Georges Dabar
Among all cancer types, pulmonary cancer has the highest mortality rate. Tobacco consumption remains the major risk factor for the development of lung cancer. However, many studies revealed a corre...

31 August 2021 in Immunotherapy
Verified
Journal Article
Closed access
EMElissar Moujaes
Elissar Moujaes
RMReine Merhy
Reine Merhy
JKJoseph Kattan
Joseph Kattan
ASAnne-Sophie Sarkis
Anne-Sophie Sarkis
RTRoland Tomb
Roland Tomb
Basal cell carcinoma (BCC) is one of the most frequent and most curable tumors at its early stages. BCC rarely metastasizes and its treatment in this setting is still challenging. Hedgehog inhibito...

24 May 2022 in Pharmacogenomics
Verified
Journal Article
Closed access
MBMariana Boulos
Mariana Boulos
EMElissar Moujaes
Elissar Moujaes
GNGhazi Nsouli
Ghazi Nsouli
ATArafat Tfayli
Arafat Tfayli
HKHampig Raphael Kourie
Hampig Raphael Kourie
Talazoparib is an oral PARP inhibitor approved for locally advanced/metastatic breast cancer. There is no consensus, however, as to whether it is better used as a first-line treatment or after othe...